Lunai Bioworks Inc. (LNAI)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States, Canada, and the Netherlands. It operates through two segments, RENB and BioSymetrics. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops BioSymetrics platform, for multi-omics integration for target identification and validation; clinical trial optimization, including patient stratification and response monitoring; and screening of gene and small molecule effects for the purpose of identifying novel drug targets and therapeutics. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is based in Sacramento, California.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Lunai Bioworks Inc. — PRE 14A Filing
# 🧾 What This Document Is This is a **PRELIMINARY PROXY STATEMENT (PRE 14A)**. Think of it as an advance notice and information packet sent to shareholders before a major vote. Lunai Bioworks is calling a special meeting because they need shareholders to approve a critical move to stay listed on th
March 2026
Lunai Bioworks Inc. — 8-K Filing
# 🔖 What This Document Is This is an **8-K filing** with an attached **Exchange Agreement** (Exhibit 10.1). An 8-K is a "current report" companies use to announce major events to shareholders. 👉 In simple terms: Lunai Bioworks is announcing a deal to **swap company debt for ownership shares**. A
SEC filings
All filings →Insider trades
All insider trades →Lunai Bioworks Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Lunai Bioworks Inc.
All people →No officers or directors have been indexed for Lunai Bioworks Inc..